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Abstract
Backgroud: Encephalomyocarditis virus (EMCV) has been discovered on pig farms worldwide and can cause
myocarditis in piglets and reproductive failure in sows. However, little is known about the host transcriptional
responses to infection and host-pathogen interactions.
Methods: In this study, transcription profiling was performed by Illumina RNA-Sequencing (RNA-seq) to identify
EMCV induced differentially expressed genes in BHK-21 cells at serial time points (12, 24, and 30 h post infection
(hpi)), using mock infected cells as control.
Results: We identified 237, 241, and 207 differentially expressed genes (DEGs) respectively, majority of which were
up-regulated. A large number of DEGs clustered into host defense, cellular signaling and metabolism categories.
Moreover, short time series expression analysis revealed that 12 hpi was an important time point for expression
change, indicating host virus resistance.
Conclusions: This RNA-seq analysis provides the first data for understanding the network of virus host interactions
under EMCV infection in vitro, and for identifying host components which involved in the virus infection course.
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Backgroud
Encephalomyocarditis virus (EMCV) belongs to the
Cardiovirus genus of the Picornaviridae family, and is a
non-enveloped, positive single stranded RNA virus [1].
EMCV has been regarded as a worldwide distributed
zoonotic pathogen infecting a broad range of host
species including rodents, non-human primates, swine,
as well as human beings [2–4]. Since the first outbreak
in 1958, clinical outbreaks due to EMCV in swine farms
have been reported in several countries [3, 5, 6]. The
number of EMCV strains isolated from pigs and wild
animals in China is increasing in recent years [7–9].
Although pigs are the most severely infected domestic
animal species to EMCV, rodents are considered to be
the natural reservoir of the virus and play a vital role in
transmitting the virus to pigs [6]. EMCV induces acute
myocarditis with sudden death in preweaning piglets as
well as severe reproductive disorder in pregnant sows
[6, 10]. Moreover, EMCV increases the risks of xeno-
transplantation for human recipients [11]. In rodents,
EMCV induces encephalitis, member paralysis, myocar-
ditis and type 1 diabetes [12–14]. EMCV infection was
also responsible for the deaths of various animals in
zoos distributed in different countries [2, 15, 16].
As the genomic RNA of EMCV is in the cytoplasm, it
becomes translated into viral proteins which are indispens-
able for replication and viral particle formation. EMCV
manipulates the host lipid metabolism and induces cell
membrane rearrangement to generate replication organ-
elles needed for replication [17]. From virus entry into host
cells to release of mature viral particles, viral factors must
interact with multiple cellular components of host cells
and affect host transcription. However, the mechanism of
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interaction between host and virus is largely unknown, e.g.
cellular signal transduction and host cell pathological re-
sponses triggered by EMCV infection. The initial and
subsequent host responses to the virus are significant to
understand host pathogen interactions and can be investi-
gated at the transcriptional level. Next generation RNA
sequencing (RNA-seq) analysis makes the study of impact
by virus infection on host cell transcription at whole
genome scale efficient. Previous RNA-seq transcriptomic
analysis supply massive data on host transcriptional
responses to various viruses. Reinhard et al. studied
transcriptional host responses to feline immunodefi-
ciency virus and discussed the similarities of that to
HIV [18]. Moreover, RNA-seq analysis revealed that
HCV infection affected multiple metabolic pathways
in host hepatocytes [19]. Transcriptome analysis of
host and virus revealed that varicella zoster virus
(VSV) altered the differentiation of human keratino-
cyte, providing insight into the pathogenic mecha-
nisms of VSV [20]. Melina et al. discovered that
negative NF-kappa B regulators were significantly up
regulated during BVDV infection by RNA-seq, sug-
gesting a possible blocking of this signaling pathway
by the virus [21].
In the present study, we investigated the host re-
sponses induced by EMCV at different time points
(12, 24 and 30 hpi) using RNA-seq, and analyzed dif-
ferential gene expression between uninfected and in-
fected cell groups, as well as the dynamic of host
gene expression during the virus infection. The re-
sults provide the first data for understanding of the




Baby hamster kidney 21 (BHK-21) cells were maintained
in Dulbecco's modified Eagle's medium (DMEM, Gibco)
supplemented with 10% (v/v) fetal bovine serum (FBS,
HyClone) in a humidified 5% CO2 incubator at 37 °C.
EMCV PV21 strain (GenBank No. X74312) from ATCC
was propagated in BHK-21 cells for viral challenge.
Viral infection
BHK-21 cells were cultured in 75 cm2 flasks until they
reached 80% confluency. Cells were washed with 1%
phosphate buffered saline and infected with EMCV at a
multiplicity of infection (MOI) of 0.01. After incubating
for 1 h at 37 °C, the supernatant was removed and
DMEM medium supplemented with 3% FBS was added
into each flask and incubated at 37 °C. Control cells
were mock infected with FBS free DMEM and treated
in the same way in parallel, and then were harvested
(designated as 0 hpi in dynamic gene expression
analysis during EMCV infection). Subsequently, cells
were harvested at 12, 24 and 30 h after EMCV infection
for transcriptomic analysis. Three individual replicates
were set up for each time point.
Library construction and illumina sequencing
Total RNA was extracted from uninfected and infected
BHK-21 cells using TRIzol Reagent (Life technologies,
USA) according to the manufacturer's instructions. The
quality of RNA was checked by capillary electrophoresis
separation on Agilent 2100 Bioanalyzer (Agilent, USA).
RNA samples were stored at −80 °C until further use.
1 μg of total RNA (three replicates of each time point
were pooled together) were used to generate cDNA
libraries. mRNA was enriched by removing rRNAs from
the total RNA after DNase I treatment, by which long
non-coding RNAs (used in further study) were not
depleted. mRNA was chemically fragmented into 140–
160 bp fragments and used as templates to synthesize
cDNA by priming with random hexamers. The synthe-
sized cDNA fragments were purified and resolved with
elution buffer for end reparation as well as adding single
nucleotide A (adenine). The cDNA fragments were sub-
sequently connected with sequencing adapters. Suitable
fragments were selected by agarose gel electrophoresis
as templates of RCR amplification. The quantity and
quality of the cDNA libraries were assessed by Agi-
lent 2100 Bioanalyzer and ABI StepOnePlus Real-
Time PCR System. Finally, the prepared libraries were
sequenced using Illumina HiSeq™ 4000. The RNA-Seq
raw data files have been uploaded in NCBI (http://
www.ncbi.nlm.nih.gov/bioproject/356035) under the ac-
cession number PRJNA356035.
RNA-seq data analysis
RNA-seq raw data was filtered using FASTQC software
to exclude reads containing adapters, reads in which
unknown bases were more than 10% and low quality
reads. Clean reads were aligned and mapped against
hamster reference genome (http://www.ncbi.nlm.nih.
gov/genome/11998) and EMCV PV21 genome (Gen-
Bank: X74312.1) by using BWA. Bowtie was used to
map reads to hamster gene reference. To analyze the ex-
pression abundance of genes, unique mapped gene reads
were normalized by Fragments Per Kilobase of exon
model per Million mapped fragments (FPKM) and log
transformed using Cufflinks. DEGs were identified using
Cuffdiff. Genes with a fold change of larger than 1.5 and
with adjusted P values < 0.05 were considered as differ-
entially expressed. The identified DEGs were subjected
to further analysis, including Gene Ontology (GO) ana-
lysis, pathway enrichment based on Kyoto Encyclopedia
of Genes and Genomes (KEGG) database, and gene
expression dynamic analysis conducted by STEM [22].
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Real-time reverse transcription quantitative PCR (RT-qPCR)
validation
RT-qPCR was carried out to verify the gene expression
by RNA-seq analysis. 1 microgram total RNA from each
group (mock infected cells, 12 hpi, 24 hpi, and 30 hpi)
was used for reverse transcription using a PrimeScript
RT reagent kit with a gDNA Eraser (TaKaRa). Equal
amounts of RNA from three replicates were pooled to-
gether to subject to reverse transcription. All RT-qPCRs
were performed in 10 μL reactions including 1 μL of
cDNA product and 5 μL of SYBR Premix Ex TaqII
(TaKaRa). The reactions were conducted in triplicate
using a CFX96 real-time PCR machine (Bio-Rad, USA)
following the temperature protocol: Initial denaturation
95 °C for 2 min; 39 cycles of 95 °C for 10 s, 56 °C for
20 s, 72 °C for 20 s. The expression fold-changes were
calculated by the relative 2-△△Ct method and the house-
keeping gene ACTB was taken as a reference gene.
Results and discussion
Transcriptome sequencing and differential expression
analysis
To depict the global picture of host transcriptomic
response to EMCV infection, and to identify host factors
involved in the infection course, we performed RNA-seq
on Illumina platform using cDNA libraries of EMCV in-
fected and mock infected BHK-21 cells. EMCV infected
cells were harvested at 12, 24, and 30 hpi. An average of
115 million reads were generated from each sample, and
an average of 114 million reads passed the quality con-
trol. 72.6% of clean reads were mapped to the hamster
genome in the mock infected group. In 24 hpi group,
65.3% and 7.2% of clean reads were aligned to hamster
genome and EMCV genome respectively, indicating viral
RNA replication before 24 hpi. In 30 hpi group, 41.5% of
clean reads were mapped to EMCV genome, indicating
active replication of the viral RNA (Table 1). The
amounts of EMCV copies were quantified by real-time
PCR, and EMCV infection was also validated. The viral
RNA levels increased rapidly during infection (Fig. 1).
The number of DEGs (≥1.5fold, with P value < 0.05) at
each time point was shown in Table 2. 237, 241, and 207
genes were found differentially expressed at 12, 24, and
30 hpi respectively (Additional file 1: Figure S1, Table 2).
There was little difference between the total number of
DEGs at each time point, however, the percentage of
down regulated genes reduced drastically as the infec-
tion time grew. At 30 hpi, only 7.7% DEGs were down
regulated. Even at 12 hpi, majority of the DEGs were up
regulated. Moreover, DEGs with a fold change of larger
than 2 at 30 hpi were much more than that at other time
points (12 hpi and 24 hpi) (Table 2).
DEG data were further subjected to Gene Ontology
(GO) and KEGG pathway analysis. GO terms classified
the functions of all differentially expressed transcripts,
producing 41 functional types at 30 hpi, including im-
mune system process, metabolic process, response to
stimulus, and signaling (Fig. 2). We designated three
functional categories of interest based on GO func-
tional classification and KEGG pathway enrichment
(Figs. 2 and 3): host defense, signaling and metabol-
ism. Representative DEGs involved in host defense at
the three time points, as well as the KEGG pathways
which the DEGs belong to, were listed in Table 3. We
identified several innate immunity pathways responsive to
EMCV infection, including RIG-I-like receptor signaling
pathway, TGF-beta signaling pathway, and NF-kappa B
signaling pathway (Fig. 3, Table 3).
LGP2, which is demonstrated to coordinate with
MDA5 [23], showed a fold decrease at 12 h after EMCV
infection. Genomic RNA of EMCV is considered to rec-
ognized by cellular RLR receptor MDA5, not RIG-I [24].
Table 1 RNA-seq reads and map rate








Mock 115833567 114848982 72.6% 0 72.6%
12 hpi 115104413 113918838 67.3% 0 67.3%
24 hpi 115831959 114777888 65.3% 7.2% 72.5%
30 hpi 115829611 114833476 34.1% 41.5% 75.6%
Fig. 1 Quantification of EMCV RNA copies in infected BHK-21 cells.
Numbers of EMCV RNA copies in infected BHK-21 cells at 12, 24, and
30 hpi were determined by Real-time quantitative PCR
Table 2 Differentially expressed genes in EMCV infected BHK-21











Mock VS 12 hpi 237 151 86 36.3% 47
Mock VS 24 hpi 241 206 35 14.5% 56
Mock VS 30 hpi 207 191 16 7.7% 178
P < 0.05
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Fig. 3 KEGG enrichment analysis of DEGs at 30 h after EMCV infection. The x-axis represents the enrichment factor, while y-axis represents
enrichment KEGG pathways
Fig. 2 GO annotation of DEGs at 30 h after EMCV infection. The x-axis represents the functional groups, while the y-axis represents the number of genes
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Mx dynamin-like GTPases have been shown to have
antiviral activity in type I and type III interferon systems.
Recent data revealed that human MX2 served as a
restriction factor for HIV-1 and other primate lentivi-
ruses [25]. Here we showed that MX2 was down-
regulated in EMCV infected BHK-21 cells at 12 hpi. The
above results indicated a quick restriction of host anti-
viral activity by EMCV. On the other hand, antiviral
genes, TAK1 and complement C3, were found up-
regulated in this study at 24 hpi and 30 hpi, suggesting
host defense responses. Tumor necrosis factor receptor
superfamily, member 25 (TNFRSF25) transcript was
discovered decreased remarkably at 30 hpi. The same
TNFRSF25 was also found down-regulated in Japanese
encephalitis virus infected mouse spleens [26]. Recent
data indicated that knockdown of TNFRSF25 led to an
increased anti-apoptotic potential [27]. EMCV is a lytic
virus causing necrotic cell death, which counteracts host
cell antiviral immunity by inhibiting apoptosis. Down-
regulation of TNFRSF25 might contribute to this inhib-
ition. TNFAIP3 (A20) transcript expression was found
increased at 24 hpi and 30 hpi, which functions in
negative regulation of NF-kappa B signaling (Table 3).
A20 was demonstrated to inhibit TNF induced apoptosis
[28]. Furthermore, a recent study showed that deficiency
of A20 in myeloid cells improved the resistance against
influenza infection, by an enhanced innate response [29].
Thus, overexpression of A20 probably counteracted the
innate immune responses induced by EMCV infection,
however, still needs further investigation. These findings
indicated that EMCV also restricted host defense at later
infection time points.
Representative DEGs involved in signaling and the
KEGG pathways which the DEGs belong to, were listed
in Additional file 2: Table S1. Representative DEGs in-
volved in metabolism as well as the KEGG pathways
which the DEGs belong to, were listed in Additional file
3: Table S2. Several signaling pathways, including MAPK
signaling pathway, PPAR signaling pathway, mTOR
signaling pathway, were widely affected subsequent to
EMCV infection (Additional file 2: Table S1, Fig. 3). The
differential analysis also showed that multiple metab-
olism pathways, especially lipid metabolism were re-
sponsive to EMCV, including Terpenoid backbone
Table 3 Representative DEGs involved in host defenses at different time points
Mock VS 12 hpi Mock VS 24 hpi Mock VS 30 hpi
Gene ID (Symbol) Fold Gene ID (Symbol) Fold Gene ID (Symbol) Fold
101825392 (CD38) −2.63 101824408 (NLRP3) −3.57 101823322 (TRAF2) 2.57
101832339 (LGP2) −2.04 101838586 (TAK1) 2.16 101824715 (TNFRSF25) −84.75
101838791 (AP1) 2.26 101842900 (C3) 2.00 101842545 (ID3) 2.36
101842545 (ID3) −1.96 101835832 (DCN) 67.01 101842900 (C3) 3.19
101843869 (MX2) −2.00 101834866 (A20) 1.82 101834778 (ZFP36) 5.88
101836016 (IL18) −1.64 101827190 (IRF7) −1.67 101823908 (PTGS2, COX2) 4.53
101834265 (PKA) 1.67 101838791 (AP1) 1.77 101838586 (TAK1) 2.98
101834866 (A20) −1.82 101837879 (CARD6) 1.61 101835832 (DCN) 120.55




RIG-I-like receptor signaling pathway: LGP2, TAK1, IRF7, TRAF2, ATG12
Apoptosis: PKA, TRAF2
Epstein-Barr virus infection: CD38, AP1, TAK1, A20, TRAF2
TGF-beta signaling pathway: ID3, DCN, TGFB1
Influenza A: MX2, IL18, NLRP3, IRF7, AP1
NF-kappa B signaling pathway: A20, TAK1, TRAF2, PTGS2
Herpes simplex infection: C3, IRF7, TRAF2, TAK1
Cytokine-cytokine receptor interaction: TNFRSF25, IL18
HTLV-I infection: ZFP36
Complement and coagulation cascades: PI3KI, C3
NOD-like receptor signaling pathway: CARD6, TAK1, NLRP3, A20
P < 0.05
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Fig. 4 STEM analysis of short time series gene expression during EMCV infection. The number in each profile box represents the profile ID number.
Statistically significant temporal expression profiles are highlighted in color (P < 0.05). Non-white profiles of the same color grouped together based
on similarity to form a single cluster. Four time points are 0, 12, 24, and 30 h post infection
Fig. 5 Relative Quantification of DEGs by real-time PCR for verification. Real-time PCR relative expression levels of selected genes (purple) at 30 hpi were
compared with RNA-seq data (pink) at the same time point. The x-axis represents DEGs, while y-axis represents normalized fold changes of transcripts
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biosynthesis, Steroid biosynthesis, Biosynthesis of unsatur-
ated fatty acids, and Glycerophospholipid metabolism
(Additional file 3: Table S2, Fig. 3). Replication of EMCV
RNA needs to modulate host cell lipid landscape [17].
Following the deep analysis of DEGs, we saw that the
transcriptional level of host lipid metabolism were
changed by EMCV.
Dynamic host gene expression during EMCV infection
To analyze dynamic gene expression at series time
points (0, 12, 24, and 30 hpi) during EMCV infection
with RNA-seq DEG data, we performed pattern analysis
using STEM (Short Time-series Expression Miner) soft-
ware (mock infection was designated as 0 hpi). STEM is
used to analyze short time series gene expression data.
The results revealed four significant expression patterns
(P < 0.05): 1. decreasing at 12 hpi and then increasing
(red, including IL18, LGP2, A20 and TAK1); 2. increas-
ing at 12 hpi and then decreasing (green, including
WNT5A); 3. gradually increasing, part of the genes
decreasing at 12 hpi, and then increasing gradually at
later time points after infection (blue, including
PLA2G2A, TXNIP, C3, TRAF2, PTGS2, CLK1, and
ZFP36); 4. decreasing at 12 hpi and then increasing, but
back to expression level at 0 hpi (yellow, including
MRGPRG) (Additional file 4: Table S3, Fig. 4). The
STEM analysis was also supported by real-time PCR
later. Several antiviral genes, including LGP2, TAK1,
ZFP36 and C3 decreased at 12 hpi, then increased, of
which C3 increased gradually at later time after 12 hpi.
These results suggested that 12 hpi was an important
time point for expression pattern change, probably indi-
cating antagonism between virus and host. EMCV might
immediately reduce host antiviral gene expression to re-
strict antiviral activity, however, the host cells were able
to make a response later to counteract with or defeat the
restriction activity induced by EMCV, although were not
capable of inhibiting the replication of the virus.
Real-time PCR verification of differential expressions
Eighteen genes from the three functional categories were
selected for validation of our RNA-seq DEG data by
Real-time RT-qPCR (Additional file 5: Table S4). Gene
expression profiles of Real-time RT-qPCR were com-
pared with those of RNA-seq. Among the 18 genes, 16
genes exhibited similar expression patterns as compared
with RNA-seq data. The other two genes (DDX3X and
HES2) didn't have obvious expression changes based on
RT-qPCR results. Fourteen of the verified differential
expression genes were up regulated, and only two genes,
TNFRSF25 and WNT9A down regulated. ZFP36, a RNA
binding protein, which targets HIV RNA for degradation
[30], showed the most significant changes in differential
expression (Fig. 5). Nevertheless, the specific role of
ZFP36 in EMCV infection is unclear. Moreover, short
time series gene expression pattern was also verified by
real-time PCR (Additional file 6: Figure S2).
Additional files
Additional file 1: Figure S1. The Venn diagram shows common
differential expressing genes at three time points (12 hpi, 24 hpi,
and 30 hpi). (TIF 3137 kb)
Additional file 2: Table S1. Representative DEGs involved in signaling
at different time points. (DOCX 15 kb)
Additional file 3: Table S2. Representative DEGs involved in metabolism
at different time points. (DOCX 15 kb)
Additional file 4: Table S3. Representative genes in each STEM pattern
(4 patterns: red, green, blue, and yellow). (DOCX 15 kb)
Additional file 5: Table S4. Selected genes for real-time PCR verification.
(DOCX 13 kb)
Additional file 6: Figure S2. Real-time PCR verification of temporal
host gene expression regulated by EMCV. Mock infection was
designated as 0 hpi. The x-axis represents infection time, while y-axis
represents normalized fold change of transcripts. (TIF 1941 kb)
Abbreviations
DEGs: Differentially expressed genes; EMCV: Encephalomyocarditis virus;
GO: Gene otology; hpi: Hours post infection; KEGG: Kyoto encyclopedia
of genes and genomes; RNA-seq: RNA-sequencing; RT-qPCR: Reverse
transcription quantitative PCR
Acknowledgement
This work was supported by the Fundamental Research Funds for the Central
Universities of China (31920150026), Talent Recruitment Program Funds
of Northwest Minzu University (xbmuyjrc201317), National Natural Science
Foundation of China (N0. 31460665), and Program for Changjiang Scholars and
Innovative Research Team in University (IRT13091).
Availability of data and materials
The raw RNA-seq data files reported in this paper were deposited to NCBI
(http://www.ncbi.nlm.nih.gov/bioproject/356035) under the accession
number PRJNA356035.
Authors’ contributions
Ruofei Feng and Jia Wei conceived and designed this research. Jia Wei,
Haixia Zhang, Xiangrong Li, Qiongyi Li, Zhongren Ma, Jialin Bai, and Zilin
Qiao performed the experiments and analyzed the data. Jia Wei wrote the
manuscript. All authors have read and approved the manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1The Key Bio-engineering and Technology Laboratory of SEAC, Northwest
Minzu University, No. 1 Xibeixincun, Lanzhou 730030, People’s Republic of
China. 2School of Life Science and Bioengineering, Northwest Minzu
University, No. 1 Xibeixincun, Lanzhou 730030, People’s Republic of China.
3Animal cell Engineering & Technology Research Center of Gansu, Northwest
Minzu University, No. 1 Xibeixincun, Lanzhou 730030, People’s Republic of
China.
Received: 28 December 2016 Accepted: 23 February 2017
References
1. Carocci M, Bakkali-Kassimi L. The encephalomyocarditis virus. Virulence.
2012;3(4):351–67.
2. Canelli E, Luppi A, Lavazza A, Lelli D, Sozzi E, Martin AM, Gelmetti D,
Pascotto E, Sandri C, Magnone W, et al. Encephalomyocarditis virus
infection in an Italian zoo. Virol J. 2010;7:64.
Wei et al. Virology Journal  (2017) 14:45 Page 7 of 8
3. Murnane TG, Craighead JE, Mondragon H, Shelokov A. Fatal disease of
swine due to encephalomyocarditis virus. Science. 1960;131(3399):498–9.
4. Feng R, Wei J, Zhang H, Fan J, Li X, Wang D, Xie J, Qiao Z, Li M, Bai J, et al.
National serosurvey of encephalomyocarditis virus in healthy people and
pigs in China. Arch Virol. 2015;160(12):2957–64.
5. Dea S, Bilodeau R, Sauvageau R, Martineau GP. Outbreaks in Quebec pig farms
of respiratory and reproductive problems associated with encephalomyocarditis
virus. J Vet Diagn Invest. 1991;3(4):275–82.
6. Koenen F, Vanderhallen H, Castryck F, Miry C. Epidemiologic, pathogenic and
molecular analysis of recent encephalomyocarditis outbreaks in Belgium.
Zentralbl Veterinarmed B. 1999;46(4):217–31.
7. Lin W, Liu Y, Cui S, Liu H. Isolation, molecular characterization, and phylogenetic
analysis of porcine encephalomyocarditis virus strain HB10 in China. Infect
Genet Evol. 2012;12(6):1324–7.
8. Feng R, Zhang H, Wei J, Li X, Xie J, Li M, Qiao Z, Feng Y, Ma Z. Isolation,
molecular and phylogenetic analysis of encephalomyocarditis virus strain
GS01 in China. Infect Genet Evol. 2015;30:19–26.
9. Liu H, He X, Song X, Xu L, Zhang Y, Zhou G, Zhu W, Chang C, Yin Z, Shi Y, et al.
Isolation and molecular and phylogenetic analyses of encephalomyocarditis
virus from wild boar in central China. Infect Genet Evol. 2016;40:67–72.
10. Joo HS, Kim HS, Leman AD. Detection of antibody to encephalomyocarditis
virus in mummified or stillborn pigs. Arch Virol. 1988;100(1–2):131–4.
11. Brewer LA, Lwamba HC, Murtaugh MP, Palmenberg AC, Brown C, Njenga
MK. Porcine encephalomyocarditis virus persists in pig myocardium and
infects human myocardial cells. J Virol. 2001;75(23):11621–9.
12. Psalla D, Psychas V, Spyrou V, Billinis C, Papaioannou N, Vlemmas I.
Pathogenesis of experimental encephalomyocarditis: a histopathological,
immunohistochemical and virological study in mice. J Comp Pathol. 2006;
135(2–3):142–5.
13. LaRue R, Myers S, Brewer L, Shaw DP, Brown C, Seal BS, Njenga MK. A
wild-type porcine encephalomyocarditis virus containing a short poly(C)
tract is pathogenic to mice, pigs, and cynomolgus macaques. J Virol.
2003;77(17):9136–46.
14. White LL, Smith RA. D variant of encephalomyocarditis virus (EMCV-D)-
induced diabetes following natural killer cell depletion in diabetes-resistant
male C57BL/6 J mice. Viral Immunol. 1990;3(1):67–76.
15. Yeo DS, Lian JE, Fernandez CJ, Lin YN, Liaw JC, Soh ML, Lim EA, Chan KP,
Ng ML, Tan HC, et al. A highly divergent Encephalomyocarditis virus
isolated from nonhuman primates in Singapore. Virol J. 2013;10:248.
16. Lamglait B, Joris A, Romey A, Bakkali-Kassimi L, Lemberger K. Fatal
Encephalomyocarditis Virus Infection in an African Savanna Elephant
(Loxodonta Africana) in a French Zoo. J Zoo Wildl Med. 2015;46(2):393–6.
17. Dorobantu CM, Albulescu L, Harak C, Feng Q, van Kampen M, Strating JR,
Gorbalenya AE, Lohmann V, van der Schaar HM, van Kuppeveld FJ.
Modulation of the Host Lipid Landscape to Promote RNA Virus Replication:
The Picornavirus Encephalomyocarditis Virus Converges on the Pathway
Used by Hepatitis C Virus. PLoS Pathog. 2015;11(9):e1005185.
18. Ertl R, Klein D. Transcriptional profiling of the host cell response to feline
immunodeficiency virus infection. Virol J. 2014;11:52.
19. Woodhouse SD, Narayan R, Latham S, Lee S, Antrobus R, Gangadharan B,
Luo S, Schroth GP, Klenerman P, Zitzmann N. Transcriptome sequencing,
microarray, and proteomic analyses reveal cellular and metabolic impact
of hepatitis C virus infection in vitro. Hepatology. 2010;52(2):443–53.
20. Jones M, Dry IR, Frampton D, Singh M, Kanda RK, Yee MB, Kellam P, Hollinshead
M, Kinchington PR, O’Toole EA, et al. RNA-seq analysis of host and viral gene
expression highlights interaction between varicella zoster virus and keratinocyte
differentiation. PLoS Pathog. 2014;10(1):e1003896.
21. Villalba M, Fredericksen F, Otth C, Olavarria V. Transcriptomic analysis of
responses to cytopathic bovine viral diarrhea virus-1 (BVDV-1) infection in
MDBK cells. Mol Immunol. 2016;71:192–202.
22. Ernst J, Bar-Joseph Z. STEM: a tool for the analysis of short time series gene
expression data. BMC Bioinforma. 2006;7:191.
23. Bruns AM, Horvath CM. LGP2 synergy with MDA5 in RLR-mediated RNA
recognition and antiviral signaling. Cytokine. 2015;74(2):198–206.
24. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS,
Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:
polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad
Sci U S A. 2006;103(22):8459–64.
25. Haller O, Staeheli P, Schwemmle M, Kochs G. Mx GTPases: dynamin-like
antiviral machines of innate immunity. Trends Microbiol. 2015;23(3):154–63.
26. Yang Y, Ye J, Yang X, Jiang R, Chen H, Cao S. Japanese encephalitis virus
infection induces changes of mRNA profile of mouse spleen and brain.
Virol J. 2011;8:80.
27. Xu LX, Grimaldo S, Qi JW, Yang GL, Qin TT, Xiao HY, Xiang R, Xiao Z, Li LY,
Zhang ZS. Death receptor 3 mediates TNFSF15- and TNFalpha-induced
endothelial cell apoptosis. Int J Biochem Cell Biol. 2014;55:109–18.
28. Won M, Park KA, Byun HS, Sohn KC, Kim YR, Jeon J, Hong JH, Park J, Seok
JH, Kim JM, et al. Novel anti-apoptotic mechanism of A20 through targeting
ASK1 to suppress TNF-induced JNK activation. Cell Death Differ. 2010;17(12):
1830–41.
29. Maelfait J, Roose K, Bogaert P, Sze M, Saelens X, Pasparakis M, Carpentier I,
van Loo G, Beyaert R. A20 (Tnfaip3) deficiency in myeloid cells protects
against influenza A virus infection. PLoS Pathog. 2012;8(3):e1002570.
30. Maeda M, Sawa H, Tobiume M, Tokunaga K, Hasegawa H, Ichinohe T, Sata T,
Moriyama M, Hall WW, Kurata T, et al. Tristetraprolin inhibits HIV-1 production
by binding to genomic RNA. Microbes Infect. 2006;8(11):2647–56.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Wei et al. Virology Journal  (2017) 14:45 Page 8 of 8
